Coroner links Richard Norton's death to peptide overdose, urging stricter Australian regulations

Key points

• Coroner David Ryan concluded that Richard Norton's death on March 30, 2025, was triggered by an injection of unapproved peptides, specifically CJC1295 and Ipamorelin.
• Norton, 75, had been taking double the prescribed dose, a fact he disclosed to a nurse two days before his death.
• The coroner recommended that the Therapeutic Goods Administration (TGA) review and potentially restrict the use of these peptides, citing insufficient safety data.
• Dr. Jerzy Muchnicki, who prescribed the peptides, was faulted for authorizing a replacement dose without consulting records that noted Norton's incorrect dosing.
• This is believed to be the first confirmed fatality in Australia linked to unapproved peptides.

Background

Peptides have gained popularity through online influencers, often promoted for anti-aging and performance enhancement. In the U.S., some peptides are approved for specific conditions, but a grey market exists for unapproved products. Recently, U.S. Health Secretary Robert F. Kennedy Jr. has moved to broaden access to certain unapproved peptides, despite FDA concerns about safety data. This case highlights the potential dangers of unregulated peptide use, especially when patients deviate from prescribed dosages.

How outlets are covering it

NBC News and ABC News emphasize the coroner's findings and the recommendation for stricter regulations, highlighting the risks of unapproved peptides. USA Today provides additional medical context, noting that anaphylaxis, asthma, and hypertrophic cardiomyopathy were contributing factors to Norton's death. All sources agree on the timeline and the doctor's role but differ in the emphasis on the specific medical causes (cardiac arrest vs. anaphylaxis) and the broader regulatory implications.

Why it matters

This case underscores the dangers of unapproved medical treatments and the importance of adhering to prescribed dosages. It also highlights the need for stricter regulations on peptides, which are increasingly marketed through social media without adequate safety oversight. The coroner's recommendation for the TGA to restrict peptide use could influence future policies in Australia and potentially other countries.

What to watch

The Therapeutic Goods Administration (TGA) is expected to review the coroner's recommendations and consider whether to impose further restrictions on unapproved peptides. Dr. Jerzy Muchnicki has accepted accountability and will no longer prescribe peptides. The case may also influence public awareness and discussions about the safety and efficacy of peptide therapy.